Global Influenza NA Inhibitor Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Influenza NA Inhibitor market size was valued at US$ million in 2023. With growing demand in downstream market, the Influenza NA Inhibitor is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Influenza NA Inhibitor market. Influenza NA Inhibitor are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Influenza NA Inhibitor. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Influenza NA Inhibitor market.
Neuraminidase enzymes are glycoside hydrolase enzymes that cleave (cut) the glycosidic linkages of neuraminic acids. The viral neuraminidases are frequently used as antigenic determinants found on the surface of the influenza virus.
Key Features:
The report on Influenza NA Inhibitor market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Influenza NA Inhibitor market. It may include historical data, market segmentation by Type (e.g., Zanamivir, Oseltamivir), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Influenza NA Inhibitor market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Influenza NA Inhibitor market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Influenza NA Inhibitor industry. This include advancements in Influenza NA Inhibitor technology, Influenza NA Inhibitor new entrants, Influenza NA Inhibitor new investment, and other innovations that are shaping the future of Influenza NA Inhibitor.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Influenza NA Inhibitor market. It includes factors influencing customer ' purchasing decisions, preferences for Influenza NA Inhibitor product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Influenza NA Inhibitor market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Influenza NA Inhibitor market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Influenza NA Inhibitor market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Influenza NA Inhibitor industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Influenza NA Inhibitor market.
Market Segmentation:
Influenza NA Inhibitor market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Influenza NA Inhibitor market?
What factors are driving Influenza NA Inhibitor market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Influenza NA Inhibitor market opportunities vary by end market size?
How does Influenza NA Inhibitor break out type, application?
According to our LPI (LP Information) latest study, the global Influenza NA Inhibitor market size was valued at US$ million in 2023. With growing demand in downstream market, the Influenza NA Inhibitor is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Influenza NA Inhibitor market. Influenza NA Inhibitor are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Influenza NA Inhibitor. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Influenza NA Inhibitor market.
Neuraminidase enzymes are glycoside hydrolase enzymes that cleave (cut) the glycosidic linkages of neuraminic acids. The viral neuraminidases are frequently used as antigenic determinants found on the surface of the influenza virus.
Key Features:
The report on Influenza NA Inhibitor market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Influenza NA Inhibitor market. It may include historical data, market segmentation by Type (e.g., Zanamivir, Oseltamivir), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Influenza NA Inhibitor market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Influenza NA Inhibitor market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Influenza NA Inhibitor industry. This include advancements in Influenza NA Inhibitor technology, Influenza NA Inhibitor new entrants, Influenza NA Inhibitor new investment, and other innovations that are shaping the future of Influenza NA Inhibitor.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Influenza NA Inhibitor market. It includes factors influencing customer ' purchasing decisions, preferences for Influenza NA Inhibitor product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Influenza NA Inhibitor market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Influenza NA Inhibitor market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Influenza NA Inhibitor market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Influenza NA Inhibitor industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Influenza NA Inhibitor market.
Market Segmentation:
Influenza NA Inhibitor market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Zanamivir
- Oseltamivir
- Peramivir
- Influenza A Treatment
- Influenza B Treatment
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Green Cross
- Roche
- GlaxoSmithKline
- Henan DaKen Chemical
- ATK Chemical
- Chemwill Asia Co.,Ltd.
- Shionogi Co.
- NeoPharm
- Moksha8 Pharma
What is the 10-year outlook for the global Influenza NA Inhibitor market?
What factors are driving Influenza NA Inhibitor market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Influenza NA Inhibitor market opportunities vary by end market size?
How does Influenza NA Inhibitor break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Influenza NA Inhibitor Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Influenza NA Inhibitor by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Influenza NA Inhibitor by Country/Region, 2019, 2023 & 2030
2.2 Influenza NA Inhibitor Segment by Type
2.2.1 Zanamivir
2.2.2 Oseltamivir
2.2.3 Peramivir
2.3 Influenza NA Inhibitor Sales by Type
2.3.1 Global Influenza NA Inhibitor Sales Market Share by Type (2019-2024)
2.3.2 Global Influenza NA Inhibitor Revenue and Market Share by Type (2019-2024)
2.3.3 Global Influenza NA Inhibitor Sale Price by Type (2019-2024)
2.4 Influenza NA Inhibitor Segment by Application
2.4.1 Influenza A Treatment
2.4.2 Influenza B Treatment
2.5 Influenza NA Inhibitor Sales by Application
2.5.1 Global Influenza NA Inhibitor Sale Market Share by Application (2019-2024)
2.5.2 Global Influenza NA Inhibitor Revenue and Market Share by Application (2019-2024)
2.5.3 Global Influenza NA Inhibitor Sale Price by Application (2019-2024)
3 GLOBAL INFLUENZA NA INHIBITOR BY COMPANY
3.1 Global Influenza NA Inhibitor Breakdown Data by Company
3.1.1 Global Influenza NA Inhibitor Annual Sales by Company (2019-2024)
3.1.2 Global Influenza NA Inhibitor Sales Market Share by Company (2019-2024)
3.2 Global Influenza NA Inhibitor Annual Revenue by Company (2019-2024)
3.2.1 Global Influenza NA Inhibitor Revenue by Company (2019-2024)
3.2.2 Global Influenza NA Inhibitor Revenue Market Share by Company (2019-2024)
3.3 Global Influenza NA Inhibitor Sale Price by Company
3.4 Key Manufacturers Influenza NA Inhibitor Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Influenza NA Inhibitor Product Location Distribution
3.4.2 Players Influenza NA Inhibitor Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR INFLUENZA NA INHIBITOR BY GEOGRAPHIC REGION
4.1 World Historic Influenza NA Inhibitor Market Size by Geographic Region (2019-2024)
4.1.1 Global Influenza NA Inhibitor Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Influenza NA Inhibitor Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Influenza NA Inhibitor Market Size by Country/Region (2019-2024)
4.2.1 Global Influenza NA Inhibitor Annual Sales by Country/Region (2019-2024)
4.2.2 Global Influenza NA Inhibitor Annual Revenue by Country/Region (2019-2024)
4.3 Americas Influenza NA Inhibitor Sales Growth
4.4 APAC Influenza NA Inhibitor Sales Growth
4.5 Europe Influenza NA Inhibitor Sales Growth
4.6 Middle East & Africa Influenza NA Inhibitor Sales Growth
5 AMERICAS
5.1 Americas Influenza NA Inhibitor Sales by Country
5.1.1 Americas Influenza NA Inhibitor Sales by Country (2019-2024)
5.1.2 Americas Influenza NA Inhibitor Revenue by Country (2019-2024)
5.2 Americas Influenza NA Inhibitor Sales by Type
5.3 Americas Influenza NA Inhibitor Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Influenza NA Inhibitor Sales by Region
6.1.1 APAC Influenza NA Inhibitor Sales by Region (2019-2024)
6.1.2 APAC Influenza NA Inhibitor Revenue by Region (2019-2024)
6.2 APAC Influenza NA Inhibitor Sales by Type
6.3 APAC Influenza NA Inhibitor Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Influenza NA Inhibitor by Country
7.1.1 Europe Influenza NA Inhibitor Sales by Country (2019-2024)
7.1.2 Europe Influenza NA Inhibitor Revenue by Country (2019-2024)
7.2 Europe Influenza NA Inhibitor Sales by Type
7.3 Europe Influenza NA Inhibitor Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Influenza NA Inhibitor by Country
8.1.1 Middle East & Africa Influenza NA Inhibitor Sales by Country (2019-2024)
8.1.2 Middle East & Africa Influenza NA Inhibitor Revenue by Country (2019-2024)
8.2 Middle East & Africa Influenza NA Inhibitor Sales by Type
8.3 Middle East & Africa Influenza NA Inhibitor Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Influenza NA Inhibitor
10.3 Manufacturing Process Analysis of Influenza NA Inhibitor
10.4 Industry Chain Structure of Influenza NA Inhibitor
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Influenza NA Inhibitor Distributors
11.3 Influenza NA Inhibitor Customer
12 WORLD FORECAST REVIEW FOR INFLUENZA NA INHIBITOR BY GEOGRAPHIC REGION
12.1 Global Influenza NA Inhibitor Market Size Forecast by Region
12.1.1 Global Influenza NA Inhibitor Forecast by Region (2025-2030)
12.1.2 Global Influenza NA Inhibitor Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Influenza NA Inhibitor Forecast by Type
12.7 Global Influenza NA Inhibitor Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Green Cross
13.1.1 Green Cross Company Information
13.1.2 Green Cross Influenza NA Inhibitor Product Portfolios and Specifications
13.1.3 Green Cross Influenza NA Inhibitor Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Green Cross Main Business Overview
13.1.5 Green Cross Latest Developments
13.2 Roche
13.2.1 Roche Company Information
13.2.2 Roche Influenza NA Inhibitor Product Portfolios and Specifications
13.2.3 Roche Influenza NA Inhibitor Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Roche Main Business Overview
13.2.5 Roche Latest Developments
13.3 GlaxoSmithKline
13.3.1 GlaxoSmithKline Company Information
13.3.2 GlaxoSmithKline Influenza NA Inhibitor Product Portfolios and Specifications
13.3.3 GlaxoSmithKline Influenza NA Inhibitor Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 GlaxoSmithKline Main Business Overview
13.3.5 GlaxoSmithKline Latest Developments
13.4 Henan DaKen Chemical
13.4.1 Henan DaKen Chemical Company Information
13.4.2 Henan DaKen Chemical Influenza NA Inhibitor Product Portfolios and Specifications
13.4.3 Henan DaKen Chemical Influenza NA Inhibitor Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Henan DaKen Chemical Main Business Overview
13.4.5 Henan DaKen Chemical Latest Developments
13.5 ATK Chemical
13.5.1 ATK Chemical Company Information
13.5.2 ATK Chemical Influenza NA Inhibitor Product Portfolios and Specifications
13.5.3 ATK Chemical Influenza NA Inhibitor Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 ATK Chemical Main Business Overview
13.5.5 ATK Chemical Latest Developments
13.6 Chemwill Asia Co.,Ltd.
13.6.1 Chemwill Asia Co.,Ltd. Company Information
13.6.2 Chemwill Asia Co.,Ltd. Influenza NA Inhibitor Product Portfolios and Specifications
13.6.3 Chemwill Asia Co.,Ltd. Influenza NA Inhibitor Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Chemwill Asia Co.,Ltd. Main Business Overview
13.6.5 Chemwill Asia Co.,Ltd. Latest Developments
13.7 Shionogi Co.
13.7.1 Shionogi Co. Company Information
13.7.2 Shionogi Co. Influenza NA Inhibitor Product Portfolios and Specifications
13.7.3 Shionogi Co. Influenza NA Inhibitor Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Shionogi Co. Main Business Overview
13.7.5 Shionogi Co. Latest Developments
13.8 NeoPharm
13.8.1 NeoPharm Company Information
13.8.2 NeoPharm Influenza NA Inhibitor Product Portfolios and Specifications
13.8.3 NeoPharm Influenza NA Inhibitor Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 NeoPharm Main Business Overview
13.8.5 NeoPharm Latest Developments
13.9 Moksha8 Pharma
13.9.1 Moksha8 Pharma Company Information
13.9.2 Moksha8 Pharma Influenza NA Inhibitor Product Portfolios and Specifications
13.9.3 Moksha8 Pharma Influenza NA Inhibitor Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Moksha8 Pharma Main Business Overview
13.9.5 Moksha8 Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Influenza NA Inhibitor Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Influenza NA Inhibitor by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Influenza NA Inhibitor by Country/Region, 2019, 2023 & 2030
2.2 Influenza NA Inhibitor Segment by Type
2.2.1 Zanamivir
2.2.2 Oseltamivir
2.2.3 Peramivir
2.3 Influenza NA Inhibitor Sales by Type
2.3.1 Global Influenza NA Inhibitor Sales Market Share by Type (2019-2024)
2.3.2 Global Influenza NA Inhibitor Revenue and Market Share by Type (2019-2024)
2.3.3 Global Influenza NA Inhibitor Sale Price by Type (2019-2024)
2.4 Influenza NA Inhibitor Segment by Application
2.4.1 Influenza A Treatment
2.4.2 Influenza B Treatment
2.5 Influenza NA Inhibitor Sales by Application
2.5.1 Global Influenza NA Inhibitor Sale Market Share by Application (2019-2024)
2.5.2 Global Influenza NA Inhibitor Revenue and Market Share by Application (2019-2024)
2.5.3 Global Influenza NA Inhibitor Sale Price by Application (2019-2024)
3 GLOBAL INFLUENZA NA INHIBITOR BY COMPANY
3.1 Global Influenza NA Inhibitor Breakdown Data by Company
3.1.1 Global Influenza NA Inhibitor Annual Sales by Company (2019-2024)
3.1.2 Global Influenza NA Inhibitor Sales Market Share by Company (2019-2024)
3.2 Global Influenza NA Inhibitor Annual Revenue by Company (2019-2024)
3.2.1 Global Influenza NA Inhibitor Revenue by Company (2019-2024)
3.2.2 Global Influenza NA Inhibitor Revenue Market Share by Company (2019-2024)
3.3 Global Influenza NA Inhibitor Sale Price by Company
3.4 Key Manufacturers Influenza NA Inhibitor Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Influenza NA Inhibitor Product Location Distribution
3.4.2 Players Influenza NA Inhibitor Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR INFLUENZA NA INHIBITOR BY GEOGRAPHIC REGION
4.1 World Historic Influenza NA Inhibitor Market Size by Geographic Region (2019-2024)
4.1.1 Global Influenza NA Inhibitor Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Influenza NA Inhibitor Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Influenza NA Inhibitor Market Size by Country/Region (2019-2024)
4.2.1 Global Influenza NA Inhibitor Annual Sales by Country/Region (2019-2024)
4.2.2 Global Influenza NA Inhibitor Annual Revenue by Country/Region (2019-2024)
4.3 Americas Influenza NA Inhibitor Sales Growth
4.4 APAC Influenza NA Inhibitor Sales Growth
4.5 Europe Influenza NA Inhibitor Sales Growth
4.6 Middle East & Africa Influenza NA Inhibitor Sales Growth
5 AMERICAS
5.1 Americas Influenza NA Inhibitor Sales by Country
5.1.1 Americas Influenza NA Inhibitor Sales by Country (2019-2024)
5.1.2 Americas Influenza NA Inhibitor Revenue by Country (2019-2024)
5.2 Americas Influenza NA Inhibitor Sales by Type
5.3 Americas Influenza NA Inhibitor Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Influenza NA Inhibitor Sales by Region
6.1.1 APAC Influenza NA Inhibitor Sales by Region (2019-2024)
6.1.2 APAC Influenza NA Inhibitor Revenue by Region (2019-2024)
6.2 APAC Influenza NA Inhibitor Sales by Type
6.3 APAC Influenza NA Inhibitor Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Influenza NA Inhibitor by Country
7.1.1 Europe Influenza NA Inhibitor Sales by Country (2019-2024)
7.1.2 Europe Influenza NA Inhibitor Revenue by Country (2019-2024)
7.2 Europe Influenza NA Inhibitor Sales by Type
7.3 Europe Influenza NA Inhibitor Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Influenza NA Inhibitor by Country
8.1.1 Middle East & Africa Influenza NA Inhibitor Sales by Country (2019-2024)
8.1.2 Middle East & Africa Influenza NA Inhibitor Revenue by Country (2019-2024)
8.2 Middle East & Africa Influenza NA Inhibitor Sales by Type
8.3 Middle East & Africa Influenza NA Inhibitor Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Influenza NA Inhibitor
10.3 Manufacturing Process Analysis of Influenza NA Inhibitor
10.4 Industry Chain Structure of Influenza NA Inhibitor
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Influenza NA Inhibitor Distributors
11.3 Influenza NA Inhibitor Customer
12 WORLD FORECAST REVIEW FOR INFLUENZA NA INHIBITOR BY GEOGRAPHIC REGION
12.1 Global Influenza NA Inhibitor Market Size Forecast by Region
12.1.1 Global Influenza NA Inhibitor Forecast by Region (2025-2030)
12.1.2 Global Influenza NA Inhibitor Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Influenza NA Inhibitor Forecast by Type
12.7 Global Influenza NA Inhibitor Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Green Cross
13.1.1 Green Cross Company Information
13.1.2 Green Cross Influenza NA Inhibitor Product Portfolios and Specifications
13.1.3 Green Cross Influenza NA Inhibitor Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Green Cross Main Business Overview
13.1.5 Green Cross Latest Developments
13.2 Roche
13.2.1 Roche Company Information
13.2.2 Roche Influenza NA Inhibitor Product Portfolios and Specifications
13.2.3 Roche Influenza NA Inhibitor Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Roche Main Business Overview
13.2.5 Roche Latest Developments
13.3 GlaxoSmithKline
13.3.1 GlaxoSmithKline Company Information
13.3.2 GlaxoSmithKline Influenza NA Inhibitor Product Portfolios and Specifications
13.3.3 GlaxoSmithKline Influenza NA Inhibitor Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 GlaxoSmithKline Main Business Overview
13.3.5 GlaxoSmithKline Latest Developments
13.4 Henan DaKen Chemical
13.4.1 Henan DaKen Chemical Company Information
13.4.2 Henan DaKen Chemical Influenza NA Inhibitor Product Portfolios and Specifications
13.4.3 Henan DaKen Chemical Influenza NA Inhibitor Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Henan DaKen Chemical Main Business Overview
13.4.5 Henan DaKen Chemical Latest Developments
13.5 ATK Chemical
13.5.1 ATK Chemical Company Information
13.5.2 ATK Chemical Influenza NA Inhibitor Product Portfolios and Specifications
13.5.3 ATK Chemical Influenza NA Inhibitor Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 ATK Chemical Main Business Overview
13.5.5 ATK Chemical Latest Developments
13.6 Chemwill Asia Co.,Ltd.
13.6.1 Chemwill Asia Co.,Ltd. Company Information
13.6.2 Chemwill Asia Co.,Ltd. Influenza NA Inhibitor Product Portfolios and Specifications
13.6.3 Chemwill Asia Co.,Ltd. Influenza NA Inhibitor Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Chemwill Asia Co.,Ltd. Main Business Overview
13.6.5 Chemwill Asia Co.,Ltd. Latest Developments
13.7 Shionogi Co.
13.7.1 Shionogi Co. Company Information
13.7.2 Shionogi Co. Influenza NA Inhibitor Product Portfolios and Specifications
13.7.3 Shionogi Co. Influenza NA Inhibitor Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Shionogi Co. Main Business Overview
13.7.5 Shionogi Co. Latest Developments
13.8 NeoPharm
13.8.1 NeoPharm Company Information
13.8.2 NeoPharm Influenza NA Inhibitor Product Portfolios and Specifications
13.8.3 NeoPharm Influenza NA Inhibitor Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 NeoPharm Main Business Overview
13.8.5 NeoPharm Latest Developments
13.9 Moksha8 Pharma
13.9.1 Moksha8 Pharma Company Information
13.9.2 Moksha8 Pharma Influenza NA Inhibitor Product Portfolios and Specifications
13.9.3 Moksha8 Pharma Influenza NA Inhibitor Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Moksha8 Pharma Main Business Overview
13.9.5 Moksha8 Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Influenza NA Inhibitor Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Influenza NA Inhibitor Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Zanamivir
Table 4. Major Players of Oseltamivir
Table 5. Major Players of Peramivir
Table 6. Global Influenza NA Inhibitor Sales by Type (2019-2024) & (Tons)
Table 7. Global Influenza NA Inhibitor Sales Market Share by Type (2019-2024)
Table 8. Global Influenza NA Inhibitor Revenue by Type (2019-2024) & ($ million)
Table 9. Global Influenza NA Inhibitor Revenue Market Share by Type (2019-2024)
Table 10. Global Influenza NA Inhibitor Sale Price by Type (2019-2024) & (US$/Kg)
Table 11. Global Influenza NA Inhibitor Sales by Application (2019-2024) & (Tons)
Table 12. Global Influenza NA Inhibitor Sales Market Share by Application (2019-2024)
Table 13. Global Influenza NA Inhibitor Revenue by Application (2019-2024)
Table 14. Global Influenza NA Inhibitor Revenue Market Share by Application (2019-2024)
Table 15. Global Influenza NA Inhibitor Sale Price by Application (2019-2024) & (US$/Kg)
Table 16. Global Influenza NA Inhibitor Sales by Company (2019-2024) & (Tons)
Table 17. Global Influenza NA Inhibitor Sales Market Share by Company (2019-2024)
Table 18. Global Influenza NA Inhibitor Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Influenza NA Inhibitor Revenue Market Share by Company (2019-2024)
Table 20. Global Influenza NA Inhibitor Sale Price by Company (2019-2024) & (US$/Kg)
Table 21. Key Manufacturers Influenza NA Inhibitor Producing Area Distribution and Sales Area
Table 22. Players Influenza NA Inhibitor Products Offered
Table 23. Influenza NA Inhibitor Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Influenza NA Inhibitor Sales by Geographic Region (2019-2024) & (Tons)
Table 27. Global Influenza NA Inhibitor Sales Market Share Geographic Region (2019-2024)
Table 28. Global Influenza NA Inhibitor Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Influenza NA Inhibitor Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Influenza NA Inhibitor Sales by Country/Region (2019-2024) & (Tons)
Table 31. Global Influenza NA Inhibitor Sales Market Share by Country/Region (2019-2024)
Table 32. Global Influenza NA Inhibitor Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Influenza NA Inhibitor Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Influenza NA Inhibitor Sales by Country (2019-2024) & (Tons)
Table 35. Americas Influenza NA Inhibitor Sales Market Share by Country (2019-2024)
Table 36. Americas Influenza NA Inhibitor Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Influenza NA Inhibitor Revenue Market Share by Country (2019-2024)
Table 38. Americas Influenza NA Inhibitor Sales by Type (2019-2024) & (Tons)
Table 39. Americas Influenza NA Inhibitor Sales by Application (2019-2024) & (Tons)
Table 40. APAC Influenza NA Inhibitor Sales by Region (2019-2024) & (Tons)
Table 41. APAC Influenza NA Inhibitor Sales Market Share by Region (2019-2024)
Table 42. APAC Influenza NA Inhibitor Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Influenza NA Inhibitor Revenue Market Share by Region (2019-2024)
Table 44. APAC Influenza NA Inhibitor Sales by Type (2019-2024) & (Tons)
Table 45. APAC Influenza NA Inhibitor Sales by Application (2019-2024) & (Tons)
Table 46. Europe Influenza NA Inhibitor Sales by Country (2019-2024) & (Tons)
Table 47. Europe Influenza NA Inhibitor Sales Market Share by Country (2019-2024)
Table 48. Europe Influenza NA Inhibitor Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Influenza NA Inhibitor Revenue Market Share by Country (2019-2024)
Table 50. Europe Influenza NA Inhibitor Sales by Type (2019-2024) & (Tons)
Table 51. Europe Influenza NA Inhibitor Sales by Application (2019-2024) & (Tons)
Table 52. Middle East & Africa Influenza NA Inhibitor Sales by Country (2019-2024) & (Tons)
Table 53. Middle East & Africa Influenza NA Inhibitor Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Influenza NA Inhibitor Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Influenza NA Inhibitor Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Influenza NA Inhibitor Sales by Type (2019-2024) & (Tons)
Table 57. Middle East & Africa Influenza NA Inhibitor Sales by Application (2019-2024) & (Tons)
Table 58. Key Market Drivers & Growth Opportunities of Influenza NA Inhibitor
Table 59. Key Market Challenges & Risks of Influenza NA Inhibitor
Table 60. Key Industry Trends of Influenza NA Inhibitor
Table 61. Influenza NA Inhibitor Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Influenza NA Inhibitor Distributors List
Table 64. Influenza NA Inhibitor Customer List
Table 65. Global Influenza NA Inhibitor Sales Forecast by Region (2025-2030) & (Tons)
Table 66. Global Influenza NA Inhibitor Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Influenza NA Inhibitor Sales Forecast by Country (2025-2030) & (Tons)
Table 68. Americas Influenza NA Inhibitor Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Influenza NA Inhibitor Sales Forecast by Region (2025-2030) & (Tons)
Table 70. APAC Influenza NA Inhibitor Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Influenza NA Inhibitor Sales Forecast by Country (2025-2030) & (Tons)
Table 72. Europe Influenza NA Inhibitor Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Influenza NA Inhibitor Sales Forecast by Country (2025-2030) & (Tons)
Table 74. Middle East & Africa Influenza NA Inhibitor Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Influenza NA Inhibitor Sales Forecast by Type (2025-2030) & (Tons)
Table 76. Global Influenza NA Inhibitor Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Influenza NA Inhibitor Sales Forecast by Application (2025-2030) & (Tons)
Table 78. Global Influenza NA Inhibitor Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Green Cross Basic Information, Influenza NA Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 80. Green Cross Influenza NA Inhibitor Product Portfolios and Specifications
Table 81. Green Cross Influenza NA Inhibitor Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 82. Green Cross Main Business
Table 83. Green Cross Latest Developments
Table 84. Roche Basic Information, Influenza NA Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 85. Roche Influenza NA Inhibitor Product Portfolios and Specifications
Table 86. Roche Influenza NA Inhibitor Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 87. Roche Main Business
Table 88. Roche Latest Developments
Table 89. GlaxoSmithKline Basic Information, Influenza NA Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 90. GlaxoSmithKline Influenza NA Inhibitor Product Portfolios and Specifications
Table 91. GlaxoSmithKline Influenza NA Inhibitor Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 92. GlaxoSmithKline Main Business
Table 93. GlaxoSmithKline Latest Developments
Table 94. Henan DaKen Chemical Basic Information, Influenza NA Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 95. Henan DaKen Chemical Influenza NA Inhibitor Product Portfolios and Specifications
Table 96. Henan DaKen Chemical Influenza NA Inhibitor Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 97. Henan DaKen Chemical Main Business
Table 98. Henan DaKen Chemical Latest Developments
Table 99. ATK Chemical Basic Information, Influenza NA Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 100. ATK Chemical Influenza NA Inhibitor Product Portfolios and Specifications
Table 101. ATK Chemical Influenza NA Inhibitor Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 102. ATK Chemical Main Business
Table 103. ATK Chemical Latest Developments
Table 104. Chemwill Asia Co.,Ltd. Basic Information, Influenza NA Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 105. Chemwill Asia Co.,Ltd. Influenza NA Inhibitor Product Portfolios and Specifications
Table 106. Chemwill Asia Co.,Ltd. Influenza NA Inhibitor Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 107. Chemwill Asia Co.,Ltd. Main Business
Table 108. Chemwill Asia Co.,Ltd. Latest Developments
Table 109. Shionogi Co. Basic Information, Influenza NA Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 110. Shionogi Co. Influenza NA Inhibitor Product Portfolios and Specifications
Table 111. Shionogi Co. Influenza NA Inhibitor Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 112. Shionogi Co. Main Business
Table 113. Shionogi Co. Latest Developments
Table 114. NeoPharm Basic Information, Influenza NA Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 115. NeoPharm Influenza NA Inhibitor Product Portfolios and Specifications
Table 116. NeoPharm Influenza NA Inhibitor Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 117. NeoPharm Main Business
Table 118. NeoPharm Latest Developments
Table 119. Moksha8 Pharma Basic Information, Influenza NA Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 120. Moksha8 Pharma Influenza NA Inhibitor Product Portfolios and Specifications
Table 121. Moksha8 Pharma Influenza NA Inhibitor Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 122. Moksha8 Pharma Main Business
Table 123. Moksha8 Pharma Latest Developments
Table 1. Influenza NA Inhibitor Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Influenza NA Inhibitor Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Zanamivir
Table 4. Major Players of Oseltamivir
Table 5. Major Players of Peramivir
Table 6. Global Influenza NA Inhibitor Sales by Type (2019-2024) & (Tons)
Table 7. Global Influenza NA Inhibitor Sales Market Share by Type (2019-2024)
Table 8. Global Influenza NA Inhibitor Revenue by Type (2019-2024) & ($ million)
Table 9. Global Influenza NA Inhibitor Revenue Market Share by Type (2019-2024)
Table 10. Global Influenza NA Inhibitor Sale Price by Type (2019-2024) & (US$/Kg)
Table 11. Global Influenza NA Inhibitor Sales by Application (2019-2024) & (Tons)
Table 12. Global Influenza NA Inhibitor Sales Market Share by Application (2019-2024)
Table 13. Global Influenza NA Inhibitor Revenue by Application (2019-2024)
Table 14. Global Influenza NA Inhibitor Revenue Market Share by Application (2019-2024)
Table 15. Global Influenza NA Inhibitor Sale Price by Application (2019-2024) & (US$/Kg)
Table 16. Global Influenza NA Inhibitor Sales by Company (2019-2024) & (Tons)
Table 17. Global Influenza NA Inhibitor Sales Market Share by Company (2019-2024)
Table 18. Global Influenza NA Inhibitor Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Influenza NA Inhibitor Revenue Market Share by Company (2019-2024)
Table 20. Global Influenza NA Inhibitor Sale Price by Company (2019-2024) & (US$/Kg)
Table 21. Key Manufacturers Influenza NA Inhibitor Producing Area Distribution and Sales Area
Table 22. Players Influenza NA Inhibitor Products Offered
Table 23. Influenza NA Inhibitor Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Influenza NA Inhibitor Sales by Geographic Region (2019-2024) & (Tons)
Table 27. Global Influenza NA Inhibitor Sales Market Share Geographic Region (2019-2024)
Table 28. Global Influenza NA Inhibitor Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Influenza NA Inhibitor Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Influenza NA Inhibitor Sales by Country/Region (2019-2024) & (Tons)
Table 31. Global Influenza NA Inhibitor Sales Market Share by Country/Region (2019-2024)
Table 32. Global Influenza NA Inhibitor Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Influenza NA Inhibitor Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Influenza NA Inhibitor Sales by Country (2019-2024) & (Tons)
Table 35. Americas Influenza NA Inhibitor Sales Market Share by Country (2019-2024)
Table 36. Americas Influenza NA Inhibitor Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Influenza NA Inhibitor Revenue Market Share by Country (2019-2024)
Table 38. Americas Influenza NA Inhibitor Sales by Type (2019-2024) & (Tons)
Table 39. Americas Influenza NA Inhibitor Sales by Application (2019-2024) & (Tons)
Table 40. APAC Influenza NA Inhibitor Sales by Region (2019-2024) & (Tons)
Table 41. APAC Influenza NA Inhibitor Sales Market Share by Region (2019-2024)
Table 42. APAC Influenza NA Inhibitor Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Influenza NA Inhibitor Revenue Market Share by Region (2019-2024)
Table 44. APAC Influenza NA Inhibitor Sales by Type (2019-2024) & (Tons)
Table 45. APAC Influenza NA Inhibitor Sales by Application (2019-2024) & (Tons)
Table 46. Europe Influenza NA Inhibitor Sales by Country (2019-2024) & (Tons)
Table 47. Europe Influenza NA Inhibitor Sales Market Share by Country (2019-2024)
Table 48. Europe Influenza NA Inhibitor Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Influenza NA Inhibitor Revenue Market Share by Country (2019-2024)
Table 50. Europe Influenza NA Inhibitor Sales by Type (2019-2024) & (Tons)
Table 51. Europe Influenza NA Inhibitor Sales by Application (2019-2024) & (Tons)
Table 52. Middle East & Africa Influenza NA Inhibitor Sales by Country (2019-2024) & (Tons)
Table 53. Middle East & Africa Influenza NA Inhibitor Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Influenza NA Inhibitor Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Influenza NA Inhibitor Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Influenza NA Inhibitor Sales by Type (2019-2024) & (Tons)
Table 57. Middle East & Africa Influenza NA Inhibitor Sales by Application (2019-2024) & (Tons)
Table 58. Key Market Drivers & Growth Opportunities of Influenza NA Inhibitor
Table 59. Key Market Challenges & Risks of Influenza NA Inhibitor
Table 60. Key Industry Trends of Influenza NA Inhibitor
Table 61. Influenza NA Inhibitor Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Influenza NA Inhibitor Distributors List
Table 64. Influenza NA Inhibitor Customer List
Table 65. Global Influenza NA Inhibitor Sales Forecast by Region (2025-2030) & (Tons)
Table 66. Global Influenza NA Inhibitor Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Influenza NA Inhibitor Sales Forecast by Country (2025-2030) & (Tons)
Table 68. Americas Influenza NA Inhibitor Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Influenza NA Inhibitor Sales Forecast by Region (2025-2030) & (Tons)
Table 70. APAC Influenza NA Inhibitor Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Influenza NA Inhibitor Sales Forecast by Country (2025-2030) & (Tons)
Table 72. Europe Influenza NA Inhibitor Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Influenza NA Inhibitor Sales Forecast by Country (2025-2030) & (Tons)
Table 74. Middle East & Africa Influenza NA Inhibitor Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Influenza NA Inhibitor Sales Forecast by Type (2025-2030) & (Tons)
Table 76. Global Influenza NA Inhibitor Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Influenza NA Inhibitor Sales Forecast by Application (2025-2030) & (Tons)
Table 78. Global Influenza NA Inhibitor Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Green Cross Basic Information, Influenza NA Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 80. Green Cross Influenza NA Inhibitor Product Portfolios and Specifications
Table 81. Green Cross Influenza NA Inhibitor Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 82. Green Cross Main Business
Table 83. Green Cross Latest Developments
Table 84. Roche Basic Information, Influenza NA Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 85. Roche Influenza NA Inhibitor Product Portfolios and Specifications
Table 86. Roche Influenza NA Inhibitor Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 87. Roche Main Business
Table 88. Roche Latest Developments
Table 89. GlaxoSmithKline Basic Information, Influenza NA Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 90. GlaxoSmithKline Influenza NA Inhibitor Product Portfolios and Specifications
Table 91. GlaxoSmithKline Influenza NA Inhibitor Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 92. GlaxoSmithKline Main Business
Table 93. GlaxoSmithKline Latest Developments
Table 94. Henan DaKen Chemical Basic Information, Influenza NA Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 95. Henan DaKen Chemical Influenza NA Inhibitor Product Portfolios and Specifications
Table 96. Henan DaKen Chemical Influenza NA Inhibitor Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 97. Henan DaKen Chemical Main Business
Table 98. Henan DaKen Chemical Latest Developments
Table 99. ATK Chemical Basic Information, Influenza NA Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 100. ATK Chemical Influenza NA Inhibitor Product Portfolios and Specifications
Table 101. ATK Chemical Influenza NA Inhibitor Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 102. ATK Chemical Main Business
Table 103. ATK Chemical Latest Developments
Table 104. Chemwill Asia Co.,Ltd. Basic Information, Influenza NA Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 105. Chemwill Asia Co.,Ltd. Influenza NA Inhibitor Product Portfolios and Specifications
Table 106. Chemwill Asia Co.,Ltd. Influenza NA Inhibitor Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 107. Chemwill Asia Co.,Ltd. Main Business
Table 108. Chemwill Asia Co.,Ltd. Latest Developments
Table 109. Shionogi Co. Basic Information, Influenza NA Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 110. Shionogi Co. Influenza NA Inhibitor Product Portfolios and Specifications
Table 111. Shionogi Co. Influenza NA Inhibitor Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 112. Shionogi Co. Main Business
Table 113. Shionogi Co. Latest Developments
Table 114. NeoPharm Basic Information, Influenza NA Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 115. NeoPharm Influenza NA Inhibitor Product Portfolios and Specifications
Table 116. NeoPharm Influenza NA Inhibitor Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 117. NeoPharm Main Business
Table 118. NeoPharm Latest Developments
Table 119. Moksha8 Pharma Basic Information, Influenza NA Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 120. Moksha8 Pharma Influenza NA Inhibitor Product Portfolios and Specifications
Table 121. Moksha8 Pharma Influenza NA Inhibitor Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 122. Moksha8 Pharma Main Business
Table 123. Moksha8 Pharma Latest Developments
LIST OF FIGURES
Figure 1. Picture of Influenza NA Inhibitor
Figure 2. Influenza NA Inhibitor Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Influenza NA Inhibitor Sales Growth Rate 2019-2030 (Tons)
Figure 7. Global Influenza NA Inhibitor Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Influenza NA Inhibitor Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Zanamivir
Figure 10. Product Picture of Oseltamivir
Figure 11. Product Picture of Peramivir
Figure 12. Global Influenza NA Inhibitor Sales Market Share by Type in 2023
Figure 13. Global Influenza NA Inhibitor Revenue Market Share by Type (2019-2024)
Figure 14. Influenza NA Inhibitor Consumed in Influenza A Treatment
Figure 15. Global Influenza NA Inhibitor Market: Influenza A Treatment (2019-2024) & (Tons)
Figure 16. Influenza NA Inhibitor Consumed in Influenza B Treatment
Figure 17. Global Influenza NA Inhibitor Market: Influenza B Treatment (2019-2024) & (Tons)
Figure 18. Global Influenza NA Inhibitor Sales Market Share by Application (2023)
Figure 19. Global Influenza NA Inhibitor Revenue Market Share by Application in 2023
Figure 20. Influenza NA Inhibitor Sales Market by Company in 2023 (Tons)
Figure 21. Global Influenza NA Inhibitor Sales Market Share by Company in 2023
Figure 22. Influenza NA Inhibitor Revenue Market by Company in 2023 ($ Million)
Figure 23. Global Influenza NA Inhibitor Revenue Market Share by Company in 2023
Figure 24. Global Influenza NA Inhibitor Sales Market Share by Geographic Region (2019-2024)
Figure 25. Global Influenza NA Inhibitor Revenue Market Share by Geographic Region in 2023
Figure 26. Americas Influenza NA Inhibitor Sales 2019-2024 (Tons)
Figure 27. Americas Influenza NA Inhibitor Revenue 2019-2024 ($ Millions)
Figure 28. APAC Influenza NA Inhibitor Sales 2019-2024 (Tons)
Figure 29. APAC Influenza NA Inhibitor Revenue 2019-2024 ($ Millions)
Figure 30. Europe Influenza NA Inhibitor Sales 2019-2024 (Tons)
Figure 31. Europe Influenza NA Inhibitor Revenue 2019-2024 ($ Millions)
Figure 32. Middle East & Africa Influenza NA Inhibitor Sales 2019-2024 (Tons)
Figure 33. Middle East & Africa Influenza NA Inhibitor Revenue 2019-2024 ($ Millions)
Figure 34. Americas Influenza NA Inhibitor Sales Market Share by Country in 2023
Figure 35. Americas Influenza NA Inhibitor Revenue Market Share by Country in 2023
Figure 36. Americas Influenza NA Inhibitor Sales Market Share by Type (2019-2024)
Figure 37. Americas Influenza NA Inhibitor Sales Market Share by Application (2019-2024)
Figure 38. United States Influenza NA Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 39. Canada Influenza NA Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 40. Mexico Influenza NA Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 41. Brazil Influenza NA Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 42. APAC Influenza NA Inhibitor Sales Market Share by Region in 2023
Figure 43. APAC Influenza NA Inhibitor Revenue Market Share by Regions in 2023
Figure 44. APAC Influenza NA Inhibitor Sales Market Share by Type (2019-2024)
Figure 45. APAC Influenza NA Inhibitor Sales Market Share by Application (2019-2024)
Figure 46. China Influenza NA Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 47. Japan Influenza NA Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 48. South Korea Influenza NA Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 49. Southeast Asia Influenza NA Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 50. India Influenza NA Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 51. Australia Influenza NA Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 52. China Taiwan Influenza NA Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 53. Europe Influenza NA Inhibitor Sales Market Share by Country in 2023
Figure 54. Europe Influenza NA Inhibitor Revenue Market Share by Country in 2023
Figure 55. Europe Influenza NA Inhibitor Sales Market Share by Type (2019-2024)
Figure 56. Europe Influenza NA Inhibitor Sales Market Share by Application (2019-2024)
Figure 57. Germany Influenza NA Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 58. France Influenza NA Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 59. UK Influenza NA Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 60. Italy Influenza NA Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 61. Russia Influenza NA Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 62. Middle East & Africa Influenza NA Inhibitor Sales Market Share by Country in 2023
Figure 63. Middle East & Africa Influenza NA Inhibitor Revenue Market Share by Country in 2023
Figure 64. Middle East & Africa Influenza NA Inhibitor Sales Market Share by Type (2019-2024)
Figure 65. Middle East & Africa Influenza NA Inhibitor Sales Market Share by Application (2019-2024)
Figure 66. Egypt Influenza NA Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 67. South Africa Influenza NA Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 68. Israel Influenza NA Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 69. Turkey Influenza NA Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 70. GCC Country Influenza NA Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Influenza NA Inhibitor in 2023
Figure 72. Manufacturing Process Analysis of Influenza NA Inhibitor
Figure 73. Industry Chain Structure of Influenza NA Inhibitor
Figure 74. Channels of Distribution
Figure 75. Global Influenza NA Inhibitor Sales Market Forecast by Region (2025-2030)
Figure 76. Global Influenza NA Inhibitor Revenue Market Share Forecast by Region (2025-2030)
Figure 77. Global Influenza NA Inhibitor Sales Market Share Forecast by Type (2025-2030)
Figure 78. Global Influenza NA Inhibitor Revenue Market Share Forecast by Type (2025-2030)
Figure 79. Global Influenza NA Inhibitor Sales Market Share Forecast by Application (2025-2030)
Figure 80. Global Influenza NA Inhibitor Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Influenza NA Inhibitor
Figure 2. Influenza NA Inhibitor Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Influenza NA Inhibitor Sales Growth Rate 2019-2030 (Tons)
Figure 7. Global Influenza NA Inhibitor Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Influenza NA Inhibitor Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Zanamivir
Figure 10. Product Picture of Oseltamivir
Figure 11. Product Picture of Peramivir
Figure 12. Global Influenza NA Inhibitor Sales Market Share by Type in 2023
Figure 13. Global Influenza NA Inhibitor Revenue Market Share by Type (2019-2024)
Figure 14. Influenza NA Inhibitor Consumed in Influenza A Treatment
Figure 15. Global Influenza NA Inhibitor Market: Influenza A Treatment (2019-2024) & (Tons)
Figure 16. Influenza NA Inhibitor Consumed in Influenza B Treatment
Figure 17. Global Influenza NA Inhibitor Market: Influenza B Treatment (2019-2024) & (Tons)
Figure 18. Global Influenza NA Inhibitor Sales Market Share by Application (2023)
Figure 19. Global Influenza NA Inhibitor Revenue Market Share by Application in 2023
Figure 20. Influenza NA Inhibitor Sales Market by Company in 2023 (Tons)
Figure 21. Global Influenza NA Inhibitor Sales Market Share by Company in 2023
Figure 22. Influenza NA Inhibitor Revenue Market by Company in 2023 ($ Million)
Figure 23. Global Influenza NA Inhibitor Revenue Market Share by Company in 2023
Figure 24. Global Influenza NA Inhibitor Sales Market Share by Geographic Region (2019-2024)
Figure 25. Global Influenza NA Inhibitor Revenue Market Share by Geographic Region in 2023
Figure 26. Americas Influenza NA Inhibitor Sales 2019-2024 (Tons)
Figure 27. Americas Influenza NA Inhibitor Revenue 2019-2024 ($ Millions)
Figure 28. APAC Influenza NA Inhibitor Sales 2019-2024 (Tons)
Figure 29. APAC Influenza NA Inhibitor Revenue 2019-2024 ($ Millions)
Figure 30. Europe Influenza NA Inhibitor Sales 2019-2024 (Tons)
Figure 31. Europe Influenza NA Inhibitor Revenue 2019-2024 ($ Millions)
Figure 32. Middle East & Africa Influenza NA Inhibitor Sales 2019-2024 (Tons)
Figure 33. Middle East & Africa Influenza NA Inhibitor Revenue 2019-2024 ($ Millions)
Figure 34. Americas Influenza NA Inhibitor Sales Market Share by Country in 2023
Figure 35. Americas Influenza NA Inhibitor Revenue Market Share by Country in 2023
Figure 36. Americas Influenza NA Inhibitor Sales Market Share by Type (2019-2024)
Figure 37. Americas Influenza NA Inhibitor Sales Market Share by Application (2019-2024)
Figure 38. United States Influenza NA Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 39. Canada Influenza NA Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 40. Mexico Influenza NA Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 41. Brazil Influenza NA Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 42. APAC Influenza NA Inhibitor Sales Market Share by Region in 2023
Figure 43. APAC Influenza NA Inhibitor Revenue Market Share by Regions in 2023
Figure 44. APAC Influenza NA Inhibitor Sales Market Share by Type (2019-2024)
Figure 45. APAC Influenza NA Inhibitor Sales Market Share by Application (2019-2024)
Figure 46. China Influenza NA Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 47. Japan Influenza NA Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 48. South Korea Influenza NA Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 49. Southeast Asia Influenza NA Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 50. India Influenza NA Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 51. Australia Influenza NA Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 52. China Taiwan Influenza NA Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 53. Europe Influenza NA Inhibitor Sales Market Share by Country in 2023
Figure 54. Europe Influenza NA Inhibitor Revenue Market Share by Country in 2023
Figure 55. Europe Influenza NA Inhibitor Sales Market Share by Type (2019-2024)
Figure 56. Europe Influenza NA Inhibitor Sales Market Share by Application (2019-2024)
Figure 57. Germany Influenza NA Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 58. France Influenza NA Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 59. UK Influenza NA Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 60. Italy Influenza NA Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 61. Russia Influenza NA Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 62. Middle East & Africa Influenza NA Inhibitor Sales Market Share by Country in 2023
Figure 63. Middle East & Africa Influenza NA Inhibitor Revenue Market Share by Country in 2023
Figure 64. Middle East & Africa Influenza NA Inhibitor Sales Market Share by Type (2019-2024)
Figure 65. Middle East & Africa Influenza NA Inhibitor Sales Market Share by Application (2019-2024)
Figure 66. Egypt Influenza NA Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 67. South Africa Influenza NA Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 68. Israel Influenza NA Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 69. Turkey Influenza NA Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 70. GCC Country Influenza NA Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Influenza NA Inhibitor in 2023
Figure 72. Manufacturing Process Analysis of Influenza NA Inhibitor
Figure 73. Industry Chain Structure of Influenza NA Inhibitor
Figure 74. Channels of Distribution
Figure 75. Global Influenza NA Inhibitor Sales Market Forecast by Region (2025-2030)
Figure 76. Global Influenza NA Inhibitor Revenue Market Share Forecast by Region (2025-2030)
Figure 77. Global Influenza NA Inhibitor Sales Market Share Forecast by Type (2025-2030)
Figure 78. Global Influenza NA Inhibitor Revenue Market Share Forecast by Type (2025-2030)
Figure 79. Global Influenza NA Inhibitor Sales Market Share Forecast by Application (2025-2030)
Figure 80. Global Influenza NA Inhibitor Revenue Market Share Forecast by Application (2025-2030)
